Stelara ® (ustekinumab) – Expanded indication
July 30, 2020 - Janssen announced the FDA approval of Stelara (ustekinumab), for the treatment of patients 6 years or older with moderate to severe plaque psoriasis (PsO) who are candidates for phototherapy or systemic therapy.
Download PDF
